Robot-Assisted Gait Training in Older Patients with Comorbid Conditions: A Pilot Study.
Saved in:
| Title: | Robot-Assisted Gait Training in Older Patients with Comorbid Conditions: A Pilot Study. |
|---|---|
| Authors: | Choi, Seung Ick, Lim, So Jeong, Kim, Na Young |
| Source: | Experimental Aging Research. Oct-Dec2025, Vol. 51 Issue 5, p597-609. 13p. |
| Subjects: | Skeletal muscle physiology, Physical therapy, Exercise physiology, Pulse oximetry, Patient safety, Research funding, Heart rate monitoring, Data analysis, Mental health, Pilot projects, Questionnaires, Functional assessment, Body composition, Interviewing, Gait disorders, Exercise intensity, Parkinson's disease, Descriptive statistics, Neurological disorders, Muscle strength, Longitudinal method, Knee joint, Robotics, Stroke rehabilitation, Quality of life, Sitting position, Statistics, Social skills, Patient satisfaction, Psychological tests, Exercise tests, Data analysis software, Walking speed, Human comfort, Central nervous system diseases, Comorbidity, Postural balance, Mental depression, Physical mobility, Physical activity, Isokinetic exercise, Muscle contraction, Disease complications, Psychosocial factors, Old age |
| Geographic Terms: | South Korea |
| Abstract: | Purpose: This study aimed to evaluate the efficacy of robot-assisted gait training (RAGT) in older patients with neurological gait disorder accompanied by various comorbidities. Materials and methods: We included Individuals aged ≥65 years with degenerative brain diseases or stroke causing gait disorders for >6 months in open-label, a pilot study. RAGT was performed for 30 min/day, 2 days/week for 12 weeks. The intensity was set to 60% of the individual's heart rate maximum reserve. Primary outcome measures were the Timed Up and Go (TUG) test and Berg Balance Scale (BBS). Secondary outcomes included Beck Depression Inventory (BDI), Short Form-36 (SF-36), and evaluation of satisfaction. Results: Thirteen participants completed 24 sessions. Neurological diseases included stroke (n = 7) and Parkinson's disease (n = 6); all patients had at least two other diseases. After RAGT, TUG test results significantly improved, and BBS scores increased. Furthermore, BDI scores decreased, and scores of social functioning and mental health domain in the SF-36 increased. Participants rated high scores on satisfaction of RAGT. Conclusions: Our finding showed that RAGT is a safe and effective intervention for enhancing physical function, improving quality of life, and reducing depression levels in older patients with neurological gait disorder accompanied by various comorbidities. [ABSTRACT FROM AUTHOR] |
| Copyright of Experimental Aging Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Purpose: This study aimed to evaluate the efficacy of robot-assisted gait training (RAGT) in older patients with neurological gait disorder accompanied by various comorbidities. Materials and methods: We included Individuals aged ≥65 years with degenerative brain diseases or stroke causing gait disorders for >6 months in open-label, a pilot study. RAGT was performed for 30 min/day, 2 days/week for 12 weeks. The intensity was set to 60% of the individual's heart rate maximum reserve. Primary outcome measures were the Timed Up and Go (TUG) test and Berg Balance Scale (BBS). Secondary outcomes included Beck Depression Inventory (BDI), Short Form-36 (SF-36), and evaluation of satisfaction. Results: Thirteen participants completed 24 sessions. Neurological diseases included stroke (n = 7) and Parkinson's disease (n = 6); all patients had at least two other diseases. After RAGT, TUG test results significantly improved, and BBS scores increased. Furthermore, BDI scores decreased, and scores of social functioning and mental health domain in the SF-36 increased. Participants rated high scores on satisfaction of RAGT. Conclusions: Our finding showed that RAGT is a safe and effective intervention for enhancing physical function, improving quality of life, and reducing depression levels in older patients with neurological gait disorder accompanied by various comorbidities. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 0361073X |
| DOI: | 10.1080/0361073X.2025.2459546 |
